SINTX Technologies Inc

SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SALT LAKE CITY, UT, July  14, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications is pleased to announce that it has received a letter from the NASDAQ Listing Qualifications Staff notifying the Company that it has regained compliance with NASDAQ's minimum bid price requirements for continued listing on the Nasdaq Capital Market. The letter noted that as a result of the closing bid price of the Company's common stock having been at $1.00 per share or greater for at least ten consecutive business days, from June 22, 2020 to July 8, 2020, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed.

SINTX Technologies Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

Evoke Pharma

Francesca's Holdings

Neonode

Last Friday was my 56th consecutive green day of trading and I ended up ending it with a gross profit of $225,000, which easily blows past the $1 million mark for the streak and is several magnitudes better than the profits from the streak it replaces.

The End Of A Record Green Streak, The Beginning Of Something New

SALT LAKE CITY, UT, June  26, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced that it has entered into a share purchase agreement with several institutional investors for the issuance and sale of 2,400,000 shares of its common stock at a price of $1.72 per share, for aggregate gross proceeds of approximately $4.1 million, in a registered direct offering priced at-the-market under Nasdaq rules.

SINTX Technologies Announces Pricing of $4.1 Million Registered Direct Offering Priced At-The-Market

SALT LAKE CITY--(BUSINESS WIRE)--SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced positive testing results demonstrating the anti-viral properties of its silicon nitride which may be useful in the reduction of the spread of COVID-19. The study results demonstrated that SINTX’s unique grade of silicon nitride inactivates the SARS-CoV-2 virus within a minut

SINTX Technologies Announces Publication of Study to Reduce the Spread and Transfer of Coronavirus

Silicon nitride demonstrates anti-viral properties against SARS-CoV-2 and kills virus within minutes of exposure.

SINTX TECHNOLOGIES  ANNOUNCES PUBLICATION OF STUDY TO REDUCE THE SPREAD AND TRANSFER OF CORONAVIRUS

SALT LAKE CITY, UT, June  23, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced that it has entered into a share purchase agreement with several institutional investors for the issuance and sale of 3,700,000 shares of its common stock at a price of $1.50 per share, for aggregate gross proceeds of approximately $5.6 million, in a registered direct offering priced at-the-market under Nasdaq rules.

SINTX Technologies Announces Pricing of $5.6 Million Registered Direct Offering Priced At-The-Market

Sintx Technologies Inc. (NASDAQ: SINT) joined the list of COVID-19 stocks with a bang on Monday morning.

Sintx Tech Gains Full Coronavirus Stock Status With New Study

SINTX Technologies news of results for the company's silicon nitride powder as a coronavirus treatment has SINT stock higher on Monday.
The post SINTX Technologies News: Why SINT Stock Is Skyrocketing Today appeared first on InvestorPlace.

SINTX Technologies News: Why SINT Stock Is Skyrocketing Today

SINTX Technologies (NASDAQ: SINT) shares are trading higher after the company announced the SARS-CoV-2 virus was inactivated in a lab study when exposed to its sintered silicon nitride powder.

Why SINTX Technologies Stock Is Trading Higher Today

Shares of SiNtx Technologies Inc. SINT, +2.37% skyrocketed more than 4-fold (up 343%) in premarket trading Monday, after the original equipment manufacturer ceramics company said the SARS-CoV-2 virus which causes COVID-19 was "inactivated" when exposed to its sintered silicon nitride powder in a controlled laboratory study.

SiNtx's stock skyrockets after upbeat data on its silicon nitride powder's effect on COVID-19 virus

SALT LAKE CITY, UT, June  20, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced that in a controlled laboratory study, the SARS-CoV-2 virus was inactivated when exposed to SINTX’s sintered silicon nitride powder. The Company expects to share additional data soon, once the findings are published in a rapid-review forum.

SINTX TECHNOLOGIES ANNOUNCES SARS-COV-2 TESTING RESULTS

SALT LAKE CITY, UT, April  22, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride applications, today announced that it received notification from Nasdaq Listing Qualifications (“Nasdaq”) stating Nasdaq's determination to toll the compliance periods for bid price and market value of publicly held shares requirements through June 30, 2020. As a result, the Company now has until December 4, 2020, to regain compliance with Nasdaq Listing Rule 5550(a)(2)’s $1.00 minimum bid price requirement

SINTX TECHNOLOGIES ANNOUNCES RECEIPT OF NOTICE FROM NASDAQ TOLLING MINIMUM BID PRICE COMPLIANCE PERIOD

SALT LAKE CITY, UT, March  23, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride applications, today announced that US and international patent applications were published on March 12, 2020 in which certain claims made in the applications address the potential surface antiviral effect of silicon nitride. The US application is numbered US 2020/0779651 A1 and titled “Antipathogenic Devices and Methods Thereof.” The international application is numbered WO 2020/051004 A1 and titled “Antipathogenic Compositions and Methods Thereof.”

SINTX TECHNOLOGIES FILES PATENT RELATED TO ANTIPATHOGENIC COMPOSITIONS AND METHODS

SALT LAKE CITY, UT, March  04, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (the “Company”), an original equipment manufacturer (OEM) ceramics company that develops and commercializes silicon nitride, today announced preliminary financial results for the year ended December 31, 2019 and provided a business update.

SINTX TECHNOLOGIES RELEASES PRELIMINARY 2019 YEAR END EARNINGS REPORT AND A BUSINESS UPDATE

SALT LAKE CITY, UT, March  02, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride applications, today announced the appointment of Mark I. Froimson, M.D. to its board of directors.

SINTX TECHNOLOGIES ANNOUNCES APPOINTMENT OF MARK I. FROIMSON, M.D.

RIGHTS OFFERING OVERSUBSCRIBED BY MORE THAN 53%

SINTX TECHNOLOGIES ANNOUNCES EXPIRATION OF OVERSUBSCRIBED RIGHTS OFFERING

SALT LAKE CITY, UT, Jan.  30, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company that develops and commercializes silicon nitride for medical and non-medical applications, today announced an agreement toward establishing a collaboration framework with Nissin Manufacturing Company, Japan (“Nissin”). The companies have agreed to terms whereby Nissin and SINTX will fund research and product development activities collaboratively at a newly developed joint research center, located in Kyoto, Japan. The purpose of this collaboration is to develop new products for worldwide markets, using SINTX’s unique technology and knowledge in silicon nitride ceramics, and Nissin’s superior manufacturing technology platforms and retail channels.

SINTX TECHNOLOGIES ANNOUNCES AGREEMENT TOWARD A COLLABORATION WITH NISSIN MANUFACTURING CO., LTD.

SALT LAKE CITY, UT, Jan.  23, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company that develops and commercializes silicon nitride for medical and non-medical applications, today announced that the subscription period for the rights offering has commenced. If exercising subscription rights through a broker, dealer, bank or other nominee, rights holders should promptly contact their nominee and submit subscription documents and payment for the units subscribed for in accordance with the instructions and within the time period provided by such nominee. The broker, dealer, bank or other nominee may establish a deadline before February 3, 2020, by which instructions to exercise subscription rights, along with the required subscription payment, must be received.

SINTX TECHNOLOGIES ANNOUNCES COMMENCEMENT OF RIGHTS OFFERING SUBSCRIPTION PERIOD

SALT LAKE CITY, UT, Nov.  18, 2019  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (the “Company”), an original equipment manufacturer (OEM) ceramics company that develops and commercializes silicon nitride for medical and non-medical applications, today announced financial results for the three and nine month periods ended September 30, 2019 and provided a business update.

SINTX TECHNOLOGIES RELEASES 2019 THIRD QUARTER AND YEAR-TO-DATE EARNINGS REPORT AND PROVIDES BUSINESS UPDATE

The FDA-registered silicon nitride medical device manufacturing facility company SINTX Technologies Inc (NASDAQ: SINT) boasts five near-term catalysts that should help the stock double in value, according to Ascendiant Capital Markets.

Why This Analyst Set A $3 Price Target On SINTX Shares

News for SINTX Technologies Inc Stock (SINT)